ethyldimethylaminopropyl carbodiimide has been researched along with Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, D; Bebo, BF; Bourdette, DN; Chou, YK; Finn, T; Kaleeba, J; Miller, SD; Offner, H; Robey, I; Vandenbark, AA; Whitham, R | 1 |
1 other study(ies) available for ethyldimethylaminopropyl carbodiimide and Multiple Sclerosis
| Article | Year |
|---|---|
Differential susceptibility of human T(h)1 versus T(h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells.
Topics: Antigen Presentation; Antigen-Presenting Cells; Apoptosis; CD28 Antigens; Clonal Anergy; Cross-Linking Reagents; Ethyldimethylaminopropyl Carbodiimide; Humans; Interleukin-10; Interleukin-2; Interleukin-5; Multiple Sclerosis; Myelin Basic Protein; Receptors, Antigen, T-Cell; Signal Transduction; Simplexvirus; Tetanus Toxoid; Th1 Cells; Th2 Cells | 2000 |